Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.

Suppr

超能文献

作者信息

Eagan R T, Ingle J N, Frytak S, Rubin J, Kvols L K, Carr D T, Coles D T, O'Fallon J R

出版信息

Cancer Treat Rep. 1977 Oct;61(7):1339-45.

PMID:589599

Abstract

摘要

相似文献

Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.

Cancer Treat Rep. 1977 Oct;61(7):1339-45.

Phase II study of the combination of dianhydrogalactitol, doxorubicin, and cisplatin (DAP) in patients with advanced squamous cell lung cancer.

Cancer Treat Rep. 1981 May-Jun;65(5-6):517-9.

[Clinical experiences with Dibromdulcitol (DBD) in the treatment of cancer].

Bronches. 1971 Mar-Apr;21(2):202-6.

Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study.双去水半乳糖醇治疗肺癌的II期评估：西南肿瘤协作组研究

Cancer Treat Rep. 1981 Jan-Feb;65(1-2):115-7.

Sequential combination of vincristine, adriamycin and cyclophosphamide (VAC), and radiotherapy in advanced non-small-cell lung cancer.

Neth J Med. 1982;25(2):43-6.

cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.顺二氯二氨铂（II）、阿霉素、环磷酰胺、洛莫司汀及长春新碱治疗非小细胞肺癌：初步报告

Cancer Treat Rep. 1979 Jan;63(1):29-33.

Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.

Cancer Treat Rep. 1982 Dec;66(12):2005-11.

VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancer.

Cancer Treat Rep. 1976 Jul;60(7):949-51.

[Treatment of patients with lung cancer with a combination of nitrosomethylurea and cyclophosphane].用亚硝基甲基脲和环磷酰胺联合治疗肺癌患者

Vopr Onkol. 1975;21(8):21-5.

[Chemotherapy in advanced cancer of the lung].[晚期肺癌的化疗]

Medicina (B Aires). 1979 Jul-Aug;39(4):472-6.

引用本文的文献

Dianhydrogalactitol induces replication-dependent DNA damage in tumor cells preferentially resolved by homologous recombination.二羟甘露醇诱导肿瘤细胞中依赖复制的 DNA 损伤，这些损伤可被同源重组优先修复。

Cell Death Dis. 2018 Oct 3;9(10):1016. doi: 10.1038/s41419-018-1069-9.

Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy.Birinapant可使具有高水平细胞凋亡抑制蛋白（cIAP）的铂耐药癌对卡铂治疗敏感。

NPJ Precis Oncol. 2017;1. doi: 10.1038/s41698-017-0008-z. Epub 2017 Apr 3.

Chemotherapy in non-small cell lung cancer.非小细胞肺癌的化疗

Invest New Drugs. 2000 May;18(2):157-86. doi: 10.1023/a:1006330030333.

Is there a role for vindesine in the treatment of non-small cell lung cancer?长春地辛在非小细胞肺癌治疗中是否有作用？

Invest New Drugs. 1993 May-Aug;11(2-3):103-33. doi: 10.1007/BF00874146.

Alkylation by 1,2:5,6-dianhydrogalactitol of deoxyribonucleic acid and guanosine.1,2:5,6-二脱水半乳糖醇对脱氧核糖核酸和鸟苷的烷基化作用。

Biochem J. 1980 Mar 1;185(3):659-66. doi: 10.1042/bj1850659.

Chemotherapy of non-small cell lung cancer: clinical trials at the Memorial Sloan-Kettering Cancer Center.非小细胞肺癌的化疗：纪念斯隆凯特琳癌症中心的临床试验

World J Surg. 1981 Sep;5(5):667-73. doi: 10.1007/BF01657925.

Chemotherapy of advanced non-small cell lung cancer. A review.晚期非小细胞肺癌的化疗。综述。

Invest New Drugs. 1984;2(3):339-47. doi: 10.1007/BF00175389.

Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.晚期肺腺癌的单药化疗。综述。

Cancer Chemother Pharmacol. 1988;21(2):89-102. doi: 10.1007/BF00257354.

Combination chemotherapy for advanced adenocarcinoma of the lung. A review.晚期肺癌腺癌的联合化疗。综述。

Cancer Chemother Pharmacol. 1988;21(2):103-16. doi: 10.1007/BF00257355.

Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.异环磷酰胺联合用药（依托泊苷或顺铂）治疗非小细胞肺癌的经验。

Cancer Chemother Pharmacol. 1986;18 Suppl 2:S34-9. doi: 10.1007/BF00647449.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验